Related Experiment Video
Updated: Jun 9, 2025
A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
Published on: February 18, 2022
Targeting Sodium in Heart Failure
Filippos Triposkiadis1, Andrew Xanthopoulos2, John Skoularigis2
1School of Medicine, European University Cyprus, 2404 Nicosia, Cyprus.
Insights
Heart failure (HF) management requires balancing sodium (Na+) and water. New methods like 23Na+ MRI and wearable sensors may improve monitoring of Na+ levels and congestion in HF patients.
Area of Science:
- Cardiology
- Nephrology
- Biomedical Engineering
Background:
- Heart failure (HF) is significantly impacted by disruptions in sodium (Na+) and water balance, leading to fluid retention and edema.
- Incomplete decongestion in HF patients correlates with poorer outcomes, highlighting the need for effective Na+-targeting interventions.
- Current HF management often involves quadruple therapy, but optimizing Na+-targeting treatments remains a challenge.
Purpose of the Study:
- To evaluate the role and effectiveness of Na+-targeting interventions in managing congestion in heart failure patients.
- To explore advanced methods for monitoring tissue sodium (Na+) and guiding Na+-targeting treatments in HF.
- To investigate the clinical significance of the 3-compartment model of Na+ storage in HF.
Main Methods:
- Review of existing literature on Na+-targeting interventions (dietary restriction, hypertonic saline, diuretics) in HF.
- Discussion of novel monitoring techniques including spot urinary sodium, 23Na+ magnetic resonance imaging (MRI), and wearable sensors.
- Exploration of the 3-compartment model of Na+ storage, emphasizing non-osmotic accumulation in tissues like skin.
Main Results:
- Incomplete decongestion adversely affects HF outcomes, underscoring the importance of effective Na+ and water balance management.
- Existing metrics for HF severity have limitations in predicting and managing congestion, potentially leading to dysnatremias.
- Emerging evidence suggests spot urinary sodium can guide Na+-targeting interventions in both acute and chronic HF.
- 23Na+-MRI and wearable sensors offer promising avenues for accurate tissue Na+ quantification and monitoring.
Conclusions:
- Optimizing Na+-targeting interventions is crucial for selected HF patients on quadruple therapy.
- Advanced monitoring tools like 23Na+-MRI and wearable sensors are essential for precise tissue Na+ assessment and guiding treatment.
- Further research is needed to elucidate the clinical implications of tissue Na+ storage and its role in HF morbidity and mortality.
Abstract:
A dominant event determining the course of heart failure (HF) includes the disruption of the delicate sodium (Na+) and water balance leading to (Na+) and water retention and edema formation. Although incomplete decongestion adversely affects outcomes, it is unknown whether interventions directly targeting (Na+), such as strict dietary (Na+) restriction, intravenous hypertonic saline, and diuretics, reverse this effect. As a result, it is imperative to implement (Na+)-targeting interventions in selected HF patients with established congestion on top of quadruple therapy with angiotensin receptor neprilysin inhibitor, β-adrenergic receptor blocker, mineralocorticoid receptor antagonist, and sodium glucose cotransporter 2 inhibitor, which dramatically improves outcomes. The limited effectiveness of (Na+)-targeting treatments may be partly due to the fact that the current metrics of HF severity have a limited capacity of foreseeing and averting episodes of congestion and guiding (Na+)-targeting treatments, which often leads to dysnatremias, adversely affecting outcomes. Recent evidence suggests that spot urinary sodium measurements may be used as a guide to monitor (Na+)-targeting interventions both in chronic and acute HF. Further, the classical (2)-compartment model of (Na+) storage has been displaced by the (3)-compartment model emphasizing the non-osmotic accumulation of (Na+), chiefly in the skin. 23(Na+) magnetic resonance imaging (MRI) enables the accurate and reliable quantification of tissue (Na+). Another promising approach enabling tissue (Na+) monitoring is based on wearable devices employing ion-selective electrodes for electrolyte detection, including (Na+) and (Cl-). Undoubtably, further studies using 23(Na+)-MRI technology and wearable sensors are required to learn more about the clinical significance of tissue (Na+) storage and (Na+)-related mechanisms of morbidity and mortality in HF.
More Related Videos
11:00Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
07:49Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
Related Concept Videos
01:22Heart Failure Drugs: Diuretics
01:29Heart Failure II: Pathophysiology
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
01:26Heart Failure Drugs: Inotropic Agents
01:30Heart Failure V: Medical Management
01:22Heart Failure VI: Adjunct Therapies